Steris Plc Revenue Growth Rates (STE31), Current and Historic Growth - CSIMarket
CSIMarket
 


Steris Plc  (NYSE: STE31)
 

STE31's Revenue Growth by Quarter and Year

Steris Plc's Revenue results by quarter and year




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/STE31/growth
https://api.csimarket.com/api/v1/companies/STE31/fundamentals
https://api.csimarket.com/api/v1/companies/STE31/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
STE31 Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
4th Quarter March -
3rd Quarter December -
2nd Quarter September 1,588.60
1st Quarter June 1,492.70
FY 3,081.30





STE31 Revenue second quarter 2023 Y/Y Growth Comment
Steris Plc achieved in the second quarter 2023, above Company average Revenue rise of 51.06% year on year, to $ 1,588.60 millions.

Looking into second quarter 2023 results within Medical Equipment & Supplies industry 68 other companies have achieved higher Revenue growth. While Steris Plc' s Revenue jump of 51.06% ranks overall at the positon no. 2141 in the second quarter 2023.




STE31 Revenue ( Y/Y Growth %) 2023
FY 2022 FY 2021 FY 2020
4th Quarter March -
3rd Quarter December -
2nd Quarter September 51.06 %
1st Quarter June 23.29 %
FY   -

Financial Statements
Steris Plc's second quarter 2023 Revenue $ 1,588.60 millions STE31's Income Statement
Steris Plc's second quarter 2022 Revenue $ 1,051.64 millions Quarterly STE31's Income Statement


STE31 Revenue (Quarter on Quarter Growth %)

2023
FY 2022 FY 2021 FY 2020
4th Quarter March -
3rd Quarter December -
2nd Quarter September 6.42 %
1st Quarter June 34.18 %
FY (Year on Year)   -




Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #69
Healthcare Sector #280
Overall #2141

Revenue Y/Y Growth Statistics
High Average Low
47.55 % 12.11 % -73.4 %
(Mar 31 2022)   (Jun 30 2019)
Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #69
Healthcare Sector #280
Overall #2141
Revenue Y/Y Growth Statistics
High Average Low
47.55 % 12.11 % -73.4 %
(Mar 31 2022)   (Jun 30 2019)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Steris Plc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
23.6 % 3.09 % -18.72 %
(Sep 30 2021)  


STE31's II. Quarter Q/Q Revenue Comment
Steris Plc achieved in the II. Quarter 2023 above company average sequential Revenue increase of 6.42%, to $ 1,588.60 millions, from $1,492.70 millions in the first quarter.

Within Medical Equipment & Supplies industry 33 other companies have achieved higher Revenue quarter on quarter growth. While Steris Plc's Revenue growth quarter on quarter, overall rank is 636.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #34
Healthcare Sector #167
Overall #636
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #34
Healthcare Sector #167
Overall #636
Revenue Q/Q Growth Statistics
High Average Low
23.6 % 3.09 % -18.72 %
(Sep 30 2021)  


STE31's II. Quarter Q/Q Revenue Comment
Steris Plc achieved in the II. Quarter 2023 above company average sequential Revenue increase of 6.42%, to $ 1,588.60 millions, from $1,492.70 millions in the first quarter.

Within Medical Equipment & Supplies industry 33 other companies have achieved higher Revenue quarter on quarter growth. While Steris Plc's Revenue growth quarter on quarter, overall rank is 636.


Steris Plc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending (Sep 30 2022) 12 Months Ending (Jun 30 2022) 12 Months Ending (Mar 31 2022) 12 Months Ending (Dec 31 2021)
Cumulative Revenue 12 Months Ending $ 4,465.70
Y / Y Revenue Growth (TTM) 5.13 %
Year on Year Revenue Growth Overall Ranking # 782
Seqeuential Revenue Change (TTM) -2.12 %
Seq. Revenue Growth (TTM) Overall Ranking # 2141


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2022 period, Steris Plc's cumulative twelve months Revenue were $ 4,466 millions, company would post below average annual Revenue growth of -2.12% year on year, if the fiscal year would end at Dec 31 2022.
A slow-down in the Steris Plc's Revenue growth from the 1492.7% growth in Sep 30 2022.

In the Healthcare sector 137 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 370 to 782.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 69
Healthcare Sector # 138
Overall # 782

Revenue TTM Y/Y Growth Statistics
High Average Low
47.55 %
12.11 %
-73.4 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 69
Sector # 280
S&P 500 # 2141
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2022 period, Steris Plc's cumulative twelve months Revenue were $ 4,466 millions, company would post below average annual Revenue growth of -73.4% year on year, if the fiscal year would end at Dec 31 2022.
A slow-down in the Steris Plc's Revenue growth from the 1492.7% growth in Sep 30 2022.

In the Healthcare sector 137 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 370 to 782.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 69
Healthcare Sector # 138
Overall # 782

Revenue TTM Y/Y Growth Statistics
High Average Low
47.55 %
12.11 %
-73.4 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 69
Sector # 280
S&P 500 # 2141




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
STE31's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Keros Therapeutics Inc 88.77%$ 88.766 millions
Profound Medical Corp 85.86%$ 85.857 millions
Vivosim Labs Inc 82.14%$ 82.143 millions
Syndax Pharmaceuticals Inc 81.59%$ 81.592 millions
Nuo Therapeutics Inc 80.81%$ 80.809 millions
Iovance Biotherapeutics inc 80.07%$ 80.074 millions
Rhythm Pharmaceuticals Inc 79.59%$ 79.594 millions
Omniab Inc 78.34%$ 78.339 millions
Aclarion Inc 78.09%$ 78.086 millions
Personalis Inc 76.59%$ 76.585 millions
Delcath Systems Inc 76.05%$ 76.047 millions
Mobia Medical Inc 73.28%$ 73.280 millions
Wave Life Sciences Ltd 72.95%$ 72.950 millions
Igc Pharma Inc 71.73%$ 71.728 millions
Phathom Pharmaceuticals Inc 71.14%$ 71.142 millions
Ptc Therapeutics inc 69.57%$ 69.571 millions
Seres Therapeutics Inc 68.95%$ 68.946 millions
Alamar Biosciences Inc 68.46%$ 68.458 millions
Carlsmed Inc 66.74%$ 66.736 millions
Corcept Therapeutics Inc63.97%$ 63.974 millions
Tarsus Pharmaceuticals Inc 63.92%$ 63.921 millions
Tg Therapeutics Inc 60.74%$ 60.743 millions
Therapeuticsmd Inc 60.59%$ 60.587 millions
Heartflow Inc 60.42%$ 60.425 millions
Glaukos Corp59.02%$ 59.021 millions
X4 Pharmaceuticals Inc58.64%$ 58.640 millions
Kiniksa Pharmaceuticals International Plc58.12%$ 58.121 millions
Fennec Pharmaceuticals Inc 57.34%$ 57.342 millions
Envoy Medical Inc 57.14%$ 57.143 millions
Humacyte Inc 55.21%$ 55.208 millions


About Steris Plc Revenue Growth Rates (STE31), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Steris Plc (CIK 1757898).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-070997
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Steris Plc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.